Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr⁻/⁻ mice. [electronic resource] by
- Assini, Julia M
- Mulvihill, Erin E
- Sutherland, Brian G
- Telford, Dawn E
- Sawyez, Cynthia G
- Felder, Sarah L
- Chhoker, Sanjiv
- Edwards, Jane Y
- Gros, Robert
- Huff, Murray W
Producer: 20130903
In:
Journal of lipid research vol. 54
Availability: No items available.
|
|
5.
|
Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21. [electronic resource] by
- Assini, Julia M
- Mulvihill, Erin E
- Burke, Amy C
- Sutherland, Brian G
- Telford, Dawn E
- Chhoker, Sanjiv S
- Sawyez, Cynthia G
- Drangova, Maria
- Adams, Andrew C
- Kharitonenkov, Alexei
- Pin, Christopher L
- Huff, Murray W
Producer: 20150819
In:
Endocrinology vol. 156
Availability: No items available.
|
|
6.
|
Nobiletin attenuates VLDL overproduction, dyslipidemia, and atherosclerosis in mice with diet-induced insulin resistance. [electronic resource] by
- Mulvihill, Erin E
- Assini, Julia M
- Lee, Justin K
- Allister, Emma M
- Sutherland, Brian G
- Koppes, Julie B
- Sawyez, Cynthia G
- Edwards, Jane Y
- Telford, Dawn E
- Charbonneau, Alexandre
- St-Pierre, Philippe
- Marette, André
- Huff, Murray W
Producer: 20110628
In:
Diabetes vol. 60
Availability: No items available.
|